326 related articles for article (PubMed ID: 26517480)
21. Preventing downstream Clostridium difficile infections with upstream antibiotic management.
Malkan AD; Scholand SJ
Med Hypotheses; 2012 Jan; 78(1):136-7. PubMed ID: 22079651
[TBL] [Abstract][Full Text] [Related]
22. Use of intravenous tigecycline in patients with severe Clostridium difficile infection: a retrospective observational cohort study.
Gergely Szabo B; Kadar B; Szidonia Lenart K; Dezsenyi B; Kunovszki P; Fried K; Kamotsay K; Nikolova R; Prinz G
Clin Microbiol Infect; 2016 Dec; 22(12):990-995. PubMed ID: 27599690
[TBL] [Abstract][Full Text] [Related]
23. Clostridium difficile colitis: review of the therapeutic approach.
Joseph J; Singhal S; Patel GM; Anand S
Am J Ther; 2014; 21(5):385-94. PubMed ID: 22990077
[TBL] [Abstract][Full Text] [Related]
24. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.
Johnson S; Louie TJ; Gerding DN; Cornely OA; Chasan-Taber S; Fitts D; Gelone SP; Broom C; Davidson DM;
Clin Infect Dis; 2014 Aug; 59(3):345-54. PubMed ID: 24799326
[TBL] [Abstract][Full Text] [Related]
25. Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
Venugopal AA; Riederer K; Patel SM; Szpunar S; Jahamy H; Valenti S; Shemes SP; Khatib R; Johnson LB
Scand J Infect Dis; 2012 Apr; 44(4):243-9. PubMed ID: 22077148
[TBL] [Abstract][Full Text] [Related]
26. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
Pépin J; Valiquette L; Alary ME; Villemure P; Pelletier A; Forget K; Pépin K; Chouinard D
CMAJ; 2004 Aug; 171(5):466-72. PubMed ID: 15337727
[TBL] [Abstract][Full Text] [Related]
27. Oral Vancomycin Monotherapy Versus Combination Therapy in Solid Organ Transplant Recipients With Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study.
Korayem GB; Eljaaly K; Matthias KR; Zangeneh TT
Transplant Proc; 2018; 50(1):137-141. PubMed ID: 29407296
[TBL] [Abstract][Full Text] [Related]
28. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
Tart SB
J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and management of Clostridium difficile infection.
Dupont HL
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1216-23; quiz e73. PubMed ID: 23542332
[TBL] [Abstract][Full Text] [Related]
30. The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection.
Rokas KE; Johnson JW; Beardsley JR; Ohl CA; Luther VP; Williamson JC
Clin Infect Dis; 2015 Sep; 61(6):934-41. PubMed ID: 26024909
[TBL] [Abstract][Full Text] [Related]
31. A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programs.
Le F; Arora V; Shah DN; Salazar M; Palmer HR; Garey KW
Pharmacotherapy; 2012 Feb; 32(2):129-34. PubMed ID: 22392421
[TBL] [Abstract][Full Text] [Related]
32. [Antimicrobial therapy of Clostridium difficile infection. Systematic review and meta-analysis of the scientific evidence].
Brodszky V; Gulácsi L; Ludwig E; Prinz G; Banai J; Reményi P; Strbák B; Kertész A; Kopcsóné Németh I; Zsoldiné Urbán E; Baji P; Péntek M
Orv Hetil; 2013 Jun; 154(23):890-9. PubMed ID: 23728312
[TBL] [Abstract][Full Text] [Related]
33. Serum vancomycin concentrations after oral and intracolonic vancomycin administration in a patient with colonic discontinuity and severe
Wilke K; Helbig S; de With K
Am J Health Syst Pharm; 2018 May; 75(9):e189-e193. PubMed ID: 29691261
[TBL] [Abstract][Full Text] [Related]
34. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea.
McPherson S; Rees CJ; Ellis R; Soo S; Panter SJ
Dis Colon Rectum; 2006 May; 49(5):640-5. PubMed ID: 16525744
[TBL] [Abstract][Full Text] [Related]
35. Treatment of Clostridium difficile infection in a French university hospital.
Khanafer N; Blais L; Barbut F; Hirschel B; Vanhems P
Scand J Gastroenterol; 2015; 50(10):1253-60. PubMed ID: 25877477
[TBL] [Abstract][Full Text] [Related]
36. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
[TBL] [Abstract][Full Text] [Related]
37. Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
Kimura T; Snijder R; Sugitani T
J Infect Chemother; 2019 Aug; 25(8):615-620. PubMed ID: 30987950
[TBL] [Abstract][Full Text] [Related]
38. [Epidemiology of Clostridium difficile-associated disease (CDAD) in Salamanca].
Siller-Ruiz M; Calvo-García N; Hernández-Egido S; María-Blázquez A; de Frutos-Serna M; García-Sánchez JE
Rev Esp Quimioter; 2014 Jun; 27(2):122-6. PubMed ID: 24940894
[TBL] [Abstract][Full Text] [Related]
39. Oral teicoplanin administration suppresses recurrence of Clostridioides difficile infection: Proof of concept.
Tanaka Y; Tashiro S; Ikegami S; Enoki Y; Taguchi K; Matsumoto K
Anaerobe; 2023 Dec; 84():102789. PubMed ID: 37879532
[TBL] [Abstract][Full Text] [Related]
40. Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: a case report and review of the literature.
El-Herte RI; Baban TA; Kanj SS
Scand J Infect Dis; 2012 Mar; 44(3):228-30. PubMed ID: 22077098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
